☆ 4.8 Article

Cyclophosphamide-induced seizures in a patient with neuropsychiatric systemic lupus erythematosus (NPSLE): A case report

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Severe hyponatraemia in two patients with breast cancer caused by low-dose cyclophosphamide and precipitated by aprepitant

Shefali Parikh et al.

Summary: This study reports two cases of postmenopausal women with breast cancer who developed acute confusion and seizures after the first cycle of neoadjuvant chemotherapy. They were found to have severe hyponatraemia, with the most likely diagnosis being cyclophosphamide-associated syndrome of inappropriate antidiuretic hormone secretion. The commonly used antiemetic aprepitant was identified as the precipitating factor.

BMJ CASE REPORTS (2022)

Add to Collection

Article Immunology

Clinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China

Shangzhu Zhang et al.

Summary: The study identified common manifestations of neuropsychiatric systemic lupus erythematosus (NPSLE) patients, such as seizures, acute confusional state, and cerebral vascular disease. NPSLE patients were more likely to present typical lupus symptoms compared to non-NPSLE patients, with significantly higher disease activity and positive rates of specific antibodies.

JOURNAL OF IMMUNOLOGY RESEARCH (2021)

Add to Collection

Review Immunology

Neuropsychiatric involvement in systemic lupus erythematosus: A review

Irene Carrion-Barbera et al.

Summary: The neuropsychiatric involvement in systemic lupus erythematosus poses challenges for clinicians at both diagnostic and therapeutic levels. The prevalence of NPSLE varies widely due to factors such as different definitions, study designs, populations, and follow-up procedures. Authors have attempted to standardize definitions and develop tools to aid in diagnosis, while EULAR has provided management recommendations.

AUTOIMMUNITY REVIEWS (2021)

Add to Collection

Review Rheumatology

Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review

D. A. Papachristos et al.

Summary: The treatment of inflammatory NPSLE includes various options such as corticosteroids, cyclophosphamide, synthetic DMARDs, biologic therapies, therapeutic plasma exchange, intravenous immunoglobulin, and autologous stem cell transplant. However, there is a lack of high-quality trial data to provide firm recommendations.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)

Add to Collection

Article Medicine, General & Internal

Oral cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis: A case report

Yire Kim et al.

Summary: This case demonstrates the possibility of PRES induction due to short-term use of oral cyclophosphamide therapy. Physicians should carefully monitor neurological symptoms after oral cyclophosphamide administration in elderly patients with underlying conditions such as sepsis, renal failure and ANCA-associated vasculitis.

WORLD JOURNAL OF CLINICAL CASES (2021)

Add to Collection

Review Clinical Neurology

Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus

Meggan Mackay et al.

CURRENT OPINION IN NEUROLOGY (2020)

Add to Collection

Review Rheumatology

Review: Nervous System Disease in Systemic Lupus Erythematosus: Current Status and Future Directions

John G. Hanly et al.

ARTHRITIS & RHEUMATOLOGY (2019)

Add to Collection

Article Rheumatology

Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches

M. Postal et al.

LUPUS (2017)

Add to Collection

Article Rheumatology

Advanced MRI techniques: biomarkers in neuropsychiatric lupus

N. Sarbu et al.

LUPUS (2017)

Add to Collection

Review Oncology

The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy

Martina Ahlmann et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)

Add to Collection

Article Neurosciences

Spinal astrocytic activation contributes to mechanical allodynia in a rat model of cyclophosphamide-induced cystitis

Bolong Liu et al.

MOLECULAR PAIN (2016)

Add to Collection

Review Medicine, General & Internal

Neuropsychiatric lupus: a mosaic of clinical presentations

Shaye Kivity et al.

BMC MEDICINE (2015)

Add to Collection

Article Psychiatry

Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: cohort study using a primary care database

Trevor Hill et al.

BMC PSYCHIATRY (2015)

Add to Collection

Letter Rheumatology

A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide

M. Jabrane et al.

RHEUMATOLOGY INTERNATIONAL (2015)

Add to Collection

Review Clinical Neurology

Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers

Helene Jeltsch-David et al.

NATURE REVIEWS NEUROLOGY (2014)

Add to Collection

Article Medicine, General & Internal

Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases

Diana Dan et al.

SWISS MEDICAL WEEKLY (2014)

Add to Collection

Article Oncology

Cyclophosphamide-Induced Severe Acute Hyponatremic Encephalopathy in Patients with Breast Cancer: Report of Two Cases

Michelle Baker et al.

CASE REPORTS IN ONCOLOGY (2014)

Add to Collection

Review Clinical Neurology

Epilepsy Associated with Systemic Autoimmune Disorders

Orrin Devinsky et al.

EPILEPSY CURRENTS (2013)

Add to Collection

Review Rheumatology

Neuropsychiatric Syndromes in Systemic Lupus Erythematosus: A Meta-Analysis

Avraham Unterman et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)

Add to Collection

Article Rheumatology

Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

J. G. Hanly et al.

ANNALS OF THE RHEUMATIC DISEASES (2010)

Add to Collection

Review Oncology

Cyclophosphamide and cancer: golden anniversary

Ashkan Emadi et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2009)

Add to Collection

Article Rheumatology

Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus

L Barile-Fabris et al.

ANNALS OF THE RHEUMATIC DISEASES (2005)

Add to Collection

Article Rheumatology

Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study)

L Stojanovich et al.

LUPUS (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.